Guest guest Posted June 15, 2008 Report Share Posted June 15, 2008 Thank you Carl for your wisdom. I'd like to add, if I might, a few more comments. 1. Having worked recently for the renewal of a re-registration for chemical, I'd say EPA takes a very very very conservative approach for those kinds of products. Despite that approach, human failure occurs. I had client enter into a coma from using a particular miticide (for public use) because of a poorly evaluated product stewardship situation. 2. The benefit to society from this approach has outweighed the costs. If we reverse this, I think the cost would easily outweigh the benefit. 3. For Workers Comp, the onus is on the employer to prove that a harm did not occur. This is a different construct to better promote business prosperity and presumable public good but making the presumption in the favor of the employee. The downside is that the recovery for the affected person is not really very equitable in the eyes of many (including Canada based on some work I did there). 4. All this points to a need to properly manage the product stewardship on the front end (regulatory and non-regulatory standard of care). 5. The new requirements out of Europe under REACH will require a significant body of publicly available knowledge to be prepared (or investigated through R & D) for many many chemicals. I expect this to stifle new development (progress in the extended future) but help catch up on our overall understanding of toxicity and mechanisms. 6. Lastly, it points to the need for newer metrics for evaluating public risk (DALY, QALY, etc.) so that public health progress on the front end can limit litigation on the back end. Tony ....................................................................... " Tony " Havics, CHMM, CIH, PE pH2, LLC 5250 E US 36, Suite 830 Avon, IN 46123 www.ph2llc.com off fax cell 90% of Risk Management is knowing where to place the decimal point...any consultant can give you the other 10%(SM) This message is from pH2. This message and any attachments may contain legally privileged or confidential information, and are intended only for the individual or entity identified above as the addressee. If you are not the addressee, or if this message has been addressed to you in error, you are not authorized to read, copy, or distribute this message and any attachments, and we ask that you please delete this message and attachments (including all copies) and notify the sender by return e-mail or by phone at . Delivery of this message and any attachments to any person other than the intended recipient(s) is not intended in any way to waive confidentiality or a privilege. All personal messages express views only of the sender, which are not to be attributed to pH2 and may not be copied or distributed without this statement. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.